The molecular cause of FXS arises from loss-of-function mutations in the X-chromosome gene, FMR1. Gene silencing is thought to occur early in embryogenesis (~10–11 gestation; Willemsen et al., 2002; Hecht et al., 2017). This evidence concerns the gene FMR1 and fragile X syndrome.